Seegene, Inc. participated in the '20^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)' held in Vienna, Austria from the 10^th to the 13^th of April, and introduced products and technologies related to infectious diseases and presented a new diagnostic system for important figures in the European molecular diagnostics industry. 

ECCMID is a super event with a participation of over 10,000 experts in molecular diagnostics centering on Europe, held throughout Europe every year. The next ECCMID will be held in Milan, Italy.

This was Seegene’s third participation, and the company received much attention. Particularly, Magicplex™ Sepsis Real-time Test products, which can diagnose over 90 pathogens causing sepsis within three and a half hours, succeeded in greatly attracting multinational diagnostics companies’ attention. Seegene established its status as a global professional molecular diagnostics company having an unrivaled simultaneous and multiplex technology by introducing a new diagnostic platform, Magicplex™ diagnostic products, company wide through this congress.